跳至主要内容
临床试验/NL-OMON49034
NL-OMON49034已完成不适用

I-BALL 2: Non-invasive Disease Monitoring in Infants with Cystic Fibrosis - I-BALL 2 study

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 11(—)

入选标准

  • Subjects are eligible for this study when they are:
  • Diagnosed with CF, either by abnormal sweat test and/or confirmed with 2
  • mutations found by genetic analysis, either from heel-prick screening or
  • diagnosed later in life.
  • Aged 1, 3 or 5 years, when they undergo bronchoscopy and chest CT scan as
  • part of the routine monitoring program for CF.
  • Aged 1, 2, 3, 4, or 5 years, when they visit the outpatient clinic for
  • routine yearly follow-up, the patient will be eligible for induced Sputum,
  • exhaled breath collection and blood collection for TiMaSCAN.
  • Authorized by a written informed consent from parents to undergo a sputum
  • induction to collect Induced Sputum (IS), to collect exhaled breath for
  • Volatile Organic Compounds (VOC) analysis, to collect an extra vial of blood
  • during the routine venous puncture, a nasopharyngeal swab (during anesthesia
  • when applicable) and permission to use excess biomaterials, especially BALF
  • retrieved during bronchoscopy and coded clinical data for research. Parents
  • may choose to opt in or out for separate parts of the study.

排除标准

  • Absence of previously given informed consent for use of encoded clinical data
  • for scientific purposes.

研究者

相似试验